Retrospective Study of First-Generation Drug-Eluting Stents, Second-Generation Drug- Eluting Stents and Non-Drug Eluting Stent Methods in the Treatment.

Slides:

Advertisements

Similar presentations

A Review of a Regional Primary Percutaneous Coronary Intervention Service, with a Focus on Door to Reperfusion Times: The 2012 Auckland/Northland Experience.

Advertisements

Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis Kaivan Vaidya, MBBS, Clare.

Pre - Transcatheter Aortic Valve Implantation Workup in the Cardiac Catheterisation Laboratory Sarah Zaman, MBBS, PhD, Robert Gooley, MBBS, Liam McCormick,

Characterisation of Myocardial Injury via T1 Mapping in Early Reperfused Myocardial Infarction and its Relationship with Global and Regional Diastolic.

Impact of New-generation Hybrid Imaging Technology on Radiation Dose during Percutaneous Coronary Interventions and Trans-femoral Aortic Valve Implantations:

Hydrogen Sulfide Inhibits Human Platelet Aggregation In Vitro in Part by Interfering Gap Junction Channels: Effects of ACS14, a Hydrogen Sulfide-releasing.

Figure 1 Flow diagram of systematic review

A Randomised Controlled Trial on the Effect of Nurse-Led Educational Intervention at the Time of Catheter Ablation for Atrial Fibrillation on Quality.

Degradable Chitosan-Collagen Composites Seeded with Cells as Tissue Engineered Heart Valves Jian-Hua Fu, PhD, Man Zhao, MD, Yan-Rong Lin, BS, Xu-Dong.

Use of Aortic Homograft Conduit in Bidirectional Glenn Shunt

Su K. Metcalfe, MD, MPH, Michael T

Jonathon P. Fanning, MBBS, Stephen V. Cox, FRACP, Gregory M

Endoscopic Radial Artery Harvesting Does not Compromise Graft Patency for Coronary Artery Bypass Graft: A Meta Analysis of 2782 Patients Hong Bing Wu,

Heart, Lung and Circulation

Systematic Detection of Familial Hypercholesterolaemia in Primary Health Care: A Community Based Prospective Study of Three Methods Andrew B. Kirke,

American Heart Journal

Procedure-specific Cardiac Surgeon Volume associated with Patient outcome following Valve Surgery, but not Isolated CABG Surgery Stephanie L. Ch’ng,

Effects of Obstructive Carotid Artery Disease on Ocular Circulation and the Safety of Carotid Artery Stenting Mehmet Yunus Emiroglu, MD, Mert Evlice,

From: Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal StentsThe TAXUS V ISR Randomized Trial JAMA. 2006;295(11):

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Right Ventricular Morphology and Function in Chronic Obstructive Pulmonary Disease Patients Living at High Altitude Tolga Sinan Güvenç, MD, Hatice Betül.

Radiofrequency Ablation for Atrial Tachycardia and Atrial Flutter

Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital.

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise Matteo Ziacchi, MD, PhD,

Robert A. Guyton, MD The Annals of Thoracic Surgery

Volume 54, Issue 1, Pages (August 2009)

Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation

Median target vessel revascularization rates per 1000 patient-years of follow-up with bare metal stents (BMS) and first- and second-generation drug-eluting.

Edward J. Davies, MBBS, Ben Clayton, MBChB, Ian Lines, Guy A

Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis Julie Sze, MBBS, John.

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.

Hulya Bayiz, Mert Dumantepe, Burak Teymen, Ibrahim Uyar

Nuclear Cardiology Practices and Radiation Exposure in the Oceania Region: Results From the IAEA Nuclear Cardiology Protocols Study (INCAPS) Sinjini.

Elizabeth A. David, MD, David T

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Robert A. Guyton, MD The Annals of Thoracic Surgery

Chun Chieh Lin, PhD, MBA, Matthew P

Joshua E. Rosen, BASc, Hari B

Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery Itzhak Herz, MD, Yaron Moshkovitz, MD,

Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors Zuzana Jedlickova, Irina Burlakova, Gesine.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi.

P. Foëx British Journal of Anaesthesia

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Drug-eluting stents for in-stent restenosis

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis Michael E. Halkos, MD, S. Tanveer.

Volume 7, Issue 11, (November 2010)

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Long-Term Follow-Up of Ultraflex Metallic Stents in Benign and Malignant Central Airway Obstruction Syed A. Husain, MRCP, David Finch, BS (Hons), Manzoor.

Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis Monika Herten, PhD, Giovanni.

Ten-year experience with renal artery in-stent stenosis

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Clinical Relevance of Our Multimodality Prognostic Score

William M. Whited, MD, Paul Henley, BS, Erin M

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Five-Year Clinical Outcome of Endoscopic Versus Open Radial Artery Harvesting: A Propensity Score Analysis Gianluigi Bisleri, MD, Laura Giroletti, MD,

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

A Review of First-Line Treatment for Small-cell Lung Cancer

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy,

Presentation transcript:

Retrospective Study of First-Generation Drug-Eluting Stents, Second-Generation Drug- Eluting Stents and Non-Drug Eluting Stent Methods in the Treatment of Native Vessel In-Stent Restenosis in Real-World Clinical Practice Drew J. Yates, MBBS, Michael L. Savage, BSc, Darren L. Walters, MBBS, Owen C. Raffel, MBBS Heart, Lung and Circulation Volume 25, Issue 4, Pages 342-351 (April 2016) DOI: 10.1016/j.hlc.2015.09.002 Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 1 ISR Treatment group versus total adverse cardiac event rate. 1st-generation = first-generation DES group (paclitaxel or sirolimus-eluting stent), 2nd-generation = second-generation DES group (everolimus or zotarolimus-eluting stent), non-DES = balloon angioplasty, cutting balloon or bare-metal stent. Heart, Lung and Circulation 2016 25, 342-351DOI: (10.1016/j.hlc.2015.09.002) Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 2 Kaplan-Meier survival analysis for total adverse cardiac events. Blue line = first-generation DES treatment group (paclitaxel or sirolimus-eluting stent), Green line = second-generation DES treatment group (everolimus or zotarolimus-eluting stent), Yellow-line = non-DES treatment group (balloon angioplasty, cutting balloon, bare-metal stent). Heart, Lung and Circulation 2016 25, 342-351DOI: (10.1016/j.hlc.2015.09.002) Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions